Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04331366 · ClinicalTrials.gov registry record · NA
Bidirectional Oxygenation Valve in the Management of Pulmonary Complications of COVID-19
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT04331366 is a NA study that has completed, run by Emory University. The registered enrollment target is 2 participants.
The verdict
NCT04331366, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The objective of this study is to determine the safety, feasibility and efficacy of a bidirectional oxygenation Positive End Expiratory Pressure (PEEP) mouthpiece in coronavirus disease 2019 (COVID-19) patients requiring supplemental oxygen by non-rebreather mask.
Interventions
- DEVICE GO2 PEEP MOUTHPIECE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2020-04-08 |
| Est. Completion | 2020-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04331366
The ClinicalTrials.gov registry entry for NCT04331366 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which GO2 PEEP MOUTHPIECE is the first listed.
NCT04331366 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04331366 about?
NCT04331366 is a clinical study titled "Bidirectional Oxygenation Valve in the Management of Pulmonary Complications of COVID-19". The objective of this study is to determine the safety, feasibility and efficacy of a bidirectional oxygenation Positive End Expiratory Pressure (PEEP) mouthpiece in coronavirus disease 2019 (COVID-19) patients requiring supplemental oxygen by non-rebreather mask.
What is the current status of trial NCT04331366?
This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2020-04-08. Estimated completion is 2020-08-31.
What interventions are being tested in trial NCT04331366?
The interventions under investigation include: GO2 PEEP MOUTHPIECE (DEVICE).
Who is sponsoring clinical trial NCT04331366?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.